LSC - 2021 - Macrophages in lung adenocarcinoma

N. Giannoula, I. Lilis (ioannislilis@upatras.gr / Laboratory for Molecular Respiratory Carcinogenecis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Spella (magsp@upatras.gr / Laboratory for Molecular Respiratory Carcinogenecis, D. of Physiology, F. of Medicine, U. of Patras,Rio), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD); University Hospital, L. University and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL),Munich)

Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Session: Biology of lung cancer: preclinical and translational research
Session type: E-poster
Number: 1121

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Giannoula, I. Lilis (ioannislilis@upatras.gr / Laboratory for Molecular Respiratory Carcinogenecis, D. of Physiology, F. of Medicine, U. of Patras,Rio), M. Spella (magsp@upatras.gr / Laboratory for Molecular Respiratory Carcinogenecis, D. of Physiology, F. of Medicine, U. of Patras,Rio), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC) and Institute for Lung Biology and Disease (iLBD); University Hospital, L. University and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL),Munich). LSC - 2021 - Macrophages in lung adenocarcinoma. 1121

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC - 2018 - A requirement for mast cells in lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms
Year: 2018




LSC - 2021 - Regulation of PA200 in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


PP131 – Macrophages in lung adenocarcinoma
Source: ERS Lung Science Conference 2021
Year: 2021

LSC - 2021 - Preclinical evaluation of IL-1ß inhibition against KRAS-mutant lung adenocarcinoma
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021

LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression
Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Year: 2018

LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017

LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

LSC - 2017 - Exosomal miRNA cargo in non small-cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



LSC - 2017 - Tumor-associated macrophages promote inflammasome-dependent lung tumor progression in mice
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

LSC - 2019 - STAT-3 is activated in COPD airway epithelial cells.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019


Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017



Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer?
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Lung stem cells and lung cancer
Source: ERS Lung Science Conference 2017
Year: 2017

Pulmonary sarcomatoid carcinoma - The experience of a lung cancer unit
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016


LSC - 2019 - Neutrophil-derived microvesicles are internalised by lung epithelial cells and induce inflammatory activation
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019